Latest PLSE reports update at 2024-05-07: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Pulse Biosciences PLSE

$ 6.95 0.72%

Pulse Biosciences Financial Statements 2011-2024 | PLSE

Annual Financial Statements Pulse Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	418 M	95.7 M	340 M	794 M	303 M	220 M	303 M	68.6 M	-	-	-	-	-
Shares	48 M	33.9 M	28 M	23.2 M	20.7 M	17.1 M	14.8 M	11 M	-	-	-	-	-
Historical Prices	8.71	2.82	12.2	34.1	14	13.4	20.3	6.55	-	-	-	-	-
Net Income	-42.2 M	-58.5 M	-63.7 M	-49.9 M	-47 M	-37.5 M	-25.6 M	-9.52 M	-2.81 M	-	-	-	-
Revenue	-	700 K	1.42 M	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	11.9 M	1.97 M	500 K	600 K	600 K	800 K	500 K	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-43.6 M	-58.1 M	-63 M	-50 M	-48 M	-37.5 M	-25.6 M	-9.52 M	-4.47 M	-	-	-	-
Interest Expense	-	-	-	-	983 K	418 K	247 K	68 K	-	-	-	-	-
EBITDA	-43 M	-57.4 M	-62.5 M	-49.5 M	-47.3 M	-37.3 M	-25.1 M	-8.92 M	-3.75 M	-	-	-	-
Operating Expenses	-	-	-	-	48 M	38 M	25.8 M	9.59 M	-	-	-	-	-
General and Administrative Expenses	15.8 M	14 M	19.1 M	16.3 M	22.3 M	20 M	15.5 M	2.93 M	1.22 M	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Pulse Biosciences

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	55.2 M	55.1 M	54.9 M	44.5 M	37.4 M	37.2 M	37.2 M	31.5 M	29.7 M	29.7 M	29.6 M	26.5 M	26.1 M	25.6 M	25.2 M	21.5 M	20.8 M	20.8 M	20.8 M	20.7 M	20.7 M	17.7 M	16.9 M	16.9 M	16.8 M	16.6 M	14.4 M	14.2 M	13.8 M	13.3 M	13.3 M	9.79 M	7.56 M	7.56 M	7.56 M	7.56 M	7.56 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-10.1 M	-	-10.6 M	-9.91 M	-9.8 M	-	-18 M	-14 M	-17.3 M	-	-14.3 M	-15.3 M	-18.6 M	-	-12.9 M	-11.3 M	-11.9 M	-13.8 M	-11.7 M	-11.4 M	-10.1 M	-8.95 M	-10.8 M	-9.16 M	-8.67 M	-8.7 M	-7.49 M	-6.18 M	-3.2 M	-2.81 M	-2.77 M	-2.26 M	-1.68 M	-1.02 M	-751 K	-599 K	-444 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	265 K	444 K	-	574 K	-	-	-	9 K	21 K	78 K	143 K	218 K	290 K	332 K	135 K	118 K	137 K	56 K	128 K	39 K	41 K	39 K	34 K	31 K	3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	8.4 M	1.34 M	909 K	-	727 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-10.6 M	-	-11.3 M	-10.2 M	-9.56 M	-	-18 M	-14 M	-17.3 M	-	-14.3 M	-14.8 M	-18.5 M	-	-12.9 M	-	-	-13.8 M	-11.7 M	-11.4 M	-10.1 M	-8.95 M	-10.8 M	-9.16 M	-8.67 M	-8.7 M	-7.49 M	-6.18 M	-3.2 M	-2.81 M	-2.77 M	-2.26 M	-1.68 M	-1.54 M	-1.23 M	-956 K	-743 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	517 K	114 K	-	9 K	21 K	78 K	143 K	218 K	290 K	332 K	107 K	118 K	137 K	56 K	128 K	39 K	41 K	39 K	34 K	31 K	3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-10.5 M	-	-11.2 M	-10.1 M	-9.43 M	-	-17.8 M	-13.9 M	-17.1 M	-	-14.2 M	-14.7 M	-18.4 M	-	-12.8 M	100 K	104 K	-13.6 M	-11.6 M	-11.3 M	-9.92 M	-8.79 M	-10.6 M	-8.96 M	-8.52 M	-8.54 M	-7.39 M	-6.16 M	-3.17 M	-2.64 M	-2.74 M	-2.23 M	-1.66 M	-1.37 M	-1.22 M	-946 K	-733 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	14.8 M	18.5 M	-	12.9 M	11.4 M	12 M	13.9 M	12 M	11.6 M	10.4 M	9.06 M	10.9 M	9.3 M	8.72 M	8.83 M	7.52 M	6.22 M	3.24 M	2.84 M	2.8 M	2.26 M	1.68 M	1.54 M	1.23 M	956 K	743 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.87 M	-	3.78 M	3.53 M	3.73 M	-	3.09 M	3.79 M	4.5 M	-	4.26 M	4.2 M	5.32 M	-	4.19 M	4 M	4.07 M	7.17 M	5.61 M	5.15 M	4.4 M	3.81 M	5.68 M	5.17 M	5.38 M	5.8 M	4.43 M	3.92 M	1.34 M	1.03 M	1.08 M	665 K	644 K	417 K	408 K	243 K	156 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency